JPMorgan Chase & Co. Purchases 219,270 Shares of Global Medical REIT Inc. (NYSE:GMRE)

JPMorgan Chase & Co. grew its stake in Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 94.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 451,197 shares of the company's stock after purchasing an additional 219,270 shares during the period. JPMorgan Chase & Co. owned about 0.68% of Global Medical REIT worth $3,483,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Franklin Resources Inc. boosted its position in Global Medical REIT by 228.9% in the third quarter. Franklin Resources Inc. now owns 114,988 shares of the company's stock valued at $1,073,000 after buying an additional 80,030 shares in the last quarter. Barclays PLC grew its position in Global Medical REIT by 87.1% during the 3rd quarter. Barclays PLC now owns 154,051 shares of the company's stock worth $1,527,000 after acquiring an additional 71,704 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Global Medical REIT during the 4th quarter valued at $1,430,000. Aew Capital Management L P acquired a new position in Global Medical REIT in the fourth quarter worth $230,000. Finally, State Street Corp grew its holdings in shares of Global Medical REIT by 1.5% during the third quarter. State Street Corp now owns 1,924,433 shares of the company's stock worth $19,468,000 after purchasing an additional 28,444 shares during the last quarter. Institutional investors and hedge funds own 57.52% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, B. Riley started coverage on shares of Global Medical REIT in a research note on Thursday, April 3rd. They issued a "neutral" rating and a $9.00 target price for the company.

Global Medical REIT Trading Up 0.1 %

GMRE stock traded up $0.01 during midday trading on Friday, reaching $7.68. The stock had a trading volume of 258,177 shares, compared to its average volume of 445,992. The firm has a market cap of $513.57 million, a price-to-earnings ratio of -383.81, a PEG ratio of 1.43 and a beta of 1.12. Global Medical REIT Inc. has a twelve month low of $6.75 and a twelve month high of $10.46. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. The business has a fifty day simple moving average of $8.20 and a two-hundred day simple moving average of $8.36.

Global Medical REIT (NYSE:GMRE - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.21. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. The business had revenue of $35.16 million during the quarter, compared to the consensus estimate of $34.87 million. As a group, research analysts expect that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.

Global Medical REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 9th. Stockholders of record on Friday, March 21st were paid a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 10.94%. The ex-dividend date was Friday, March 21st. Global Medical REIT's dividend payout ratio (DPR) is currently 8,400.00%.

About Global Medical REIT

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.